Xin-Yi Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xin-Yi Chen has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Yan Xue
Department of Physiology and Pathophysiology, School of Basic Medicine, Qingdao University, Qingdao, China
6 shared publicationsCui Liu
Department of Histology and Embryology, School of Clinical and Basic Medical Sciences, Shandong First Medical University and Shandong Academy of Medical, Jinan, China
5 shared publications- Lei Chen
Department of Physiology and Pathophysiology, School of Basic Medicine, Qingdao University, Qingdao, China
5 shared publications Wen-Hong Liu
Department of Physiology and Pathophysiology, School of Basic Medicine, Qingdao University, Qingdao, China
2 shared publicationsWu Yang
Department of Geriatrics Affiliated Hospital of Qingdao University Qingdao China
2 shared publicationsAn‐Mu Xie
Department of Neurology Affiliated Hospital of Qingdao University Qingdao China
1 shared publication
Latest Publications
- Open Access
- 25 April 2025
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 17, 1529919
Activation of GLP-1R modulates the spontaneous discharge of nigral dopaminergic neurons and motor behavior in mice with chronic MPTP Parkinson's disease
The gradual decline of nigral dopaminergic neurons is the main cause of Parkinson's disease (PD), yet as of now, there exists no conclusive therapeutic intervention. Glucagon-like peptide-1 (GLP-1) is an incretin, which is also a key substance regulating neuronal activity and synaptic transmission. GLP-1 receptors (GLP-1Rs) are widely expressed in the central nervous system. Chronic administration of low doses of 1-methyl-4-phenyl, 1,2,3,6-tetrahydropiridine (MPTP) mitigates mortality in mice during the modeling phase, thereby more closely mirroring the progression of PD. This study aims to observe the effects of GLP-1 receptor agonists (GLP-1RAs) on the firing activity of nigral dopaminergic neurons and motor behaviors in MPTP-induced chronic PD mice. Our findings revealed that peripheral administration of GLP-1RAs exendin-4 significantly alleviated motor impairments in MPTP-induced chronic PD mice. Concurrently, peripheral administration of exendin-4 increased the number of active dopaminergic neurons, improved the spontaneous firing activity, as well as alleviated MPTP-induced dopaminergic neuron loss in MPTP-induced PD mice. Furthermore, local administration of exendin-4 directly increased the firing rate of nigral dopaminergic neurons via GLP-1Rs, suggesting that peripheral administration of exendin-4 may exert neuroprotection through its mild excitation on dopaminergic neurons. These findings collectively imply that peripheral administration of GLP-1RAs may hold potential in the treatment of PD.
- 25 April 2025
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 17, 1529919
Open AccessActivation of GLP-1R modulates the spontaneous discharge of nigral dopaminergic neurons and motor behavior in mice with chronic MPTP Parkinson's disease
The gradual decline of nigral dopaminergic neurons is the main cause of Parkinson's disease (PD), yet as of now, there exists no conclusive therapeutic intervention. Glucagon-like peptide-1 (GLP-1) is an incretin, which is also a key substance regulating neuronal activity and synaptic transmission. GLP-1 receptors (GLP-1Rs) are widely expressed in the central nervous system. Chronic administration of low doses of 1-methyl-4-phenyl, 1,2,3,6-tetrahydropiridine (MPTP) mitigates mortality in mice during the modeling phase, thereby more closely mirroring the progression of PD. This study aims to observe the effects of GLP-1 receptor agonists (GLP-1RAs) on the firing activity of nigral dopaminergic neurons and motor behaviors in MPTP-induced chronic PD mice. Our findings revealed that peripheral administration of GLP-1RAs exendin-4 significantly alleviated motor impairments in MPTP-induced chronic PD mice. Concurrently, peripheral administration of exendin-4 increased the number of active dopaminergic neurons, improved the spontaneous firing activity, as well as alleviated MPTP-induced dopaminergic neuron loss in MPTP-induced PD mice. Furthermore, local administration of exendin-4 directly increased the firing rate of nigral dopaminergic neurons via GLP-1Rs, suggesting that peripheral administration of exendin-4 may exert neuroprotection through its mild excitation on dopaminergic neurons. These findings collectively imply that peripheral administration of GLP-1RAs may hold potential in the treatment of PD.
- 2 August 2024
- Published by Wiley in Journal of Neurochemistry
- Vol. 168 (9) , 2379-2390
Orexin increases the neuronal excitability of several brain areas associated with maintaining of arousal
Orexin is exclusively produced in neurons localized within the lateral hypothalamic area (LHA) and perifornical area (PFA). Orexin has been identified as a key promotor of arousal. The selective loss of orexinergic neurons results in narcolepsy. It is known that the intrinsic electrophysiological properties are critical for neurons to perform their functions in corresponding brain regions. In addition to hypothalamic orexin, other brain nuclei are involved in the regulation of sleep and wakefulness. Quite a lot of studies focus on elucidating orexin‐induced regulation of sleep–wake states and modulation of neuronal electrophysiological properties in several brain regions. Here, we summarize that the orexinergic neurons exhibit spontaneous firing activity which is associated with the states of sleep–wake cycle. Orexin mainly exerts postsynaptic excitatory effects on multiple brain nuclei associated with the process of sleep and wakefulness. This review may provide a background to guide future research about the cellular mechanisms of orexin‐induced maintaining of arousal. image
- 2 August 2024
- Published by Wiley in Journal of Neurochemistry
- Vol. 168 (9) , 2379-2390
Orexin increases the neuronal excitability of several brain areas associated with maintaining of arousal
Orexin is exclusively produced in neurons localized within the lateral hypothalamic area (LHA) and perifornical area (PFA). Orexin has been identified as a key promotor of arousal. The selective loss of orexinergic neurons results in narcolepsy. It is known that the intrinsic electrophysiological properties are critical for neurons to perform their functions in corresponding brain regions. In addition to hypothalamic orexin, other brain nuclei are involved in the regulation of sleep and wakefulness. Quite a lot of studies focus on elucidating orexin‐induced regulation of sleep–wake states and modulation of neuronal electrophysiological properties in several brain regions. Here, we summarize that the orexinergic neurons exhibit spontaneous firing activity which is associated with the states of sleep–wake cycle. Orexin mainly exerts postsynaptic excitatory effects on multiple brain nuclei associated with the process of sleep and wakefulness. This review may provide a background to guide future research about the cellular mechanisms of orexin‐induced maintaining of arousal. image
- Open Access
- 9 April 2024
- Published by Elsevier in Neuropharmacology
- Vol. 252, 109946
GLP-1 modulated the firing activity of nigral dopaminergic neurons in both normal and parkinsonian mice
- 9 April 2024
- Published by Elsevier in Neuropharmacology
- Vol. 252, 109946
Open AccessGLP-1 modulated the firing activity of nigral dopaminergic neurons in both normal and parkinsonian mice
- Open Access
- 1 April 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 174, 116518
Inhibition of calcium-sensing receptor by its antagonist promotes gastrointestinal motility in a Parkinson’s disease mouse model
- 1 April 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 174, 116518
Open AccessInhibition of calcium-sensing receptor by its antagonist promotes gastrointestinal motility in a Parkinson’s disease mouse model
- Open Access
- 16 August 2023
- Published by Elsevier in Neuroscience Research
- Vol. 199, 48-56
Exendin-4 increases the firing activity of hippocampal CA1 neurons through TRPC4/5 channels
- 16 August 2023
- Published by Elsevier in Neuroscience Research
- Vol. 199, 48-56
Open AccessExendin-4 increases the firing activity of hippocampal CA1 neurons through TRPC4/5 channels
- 15 April 2023
- Published by Elsevier in Neuropeptides
- Vol. 99, 102337
Several neuropeptides involved in parkinsonian neuroprotection modulate the firing properties of nigral dopaminergic neurons
- 15 April 2023
- Published by Elsevier in Neuropeptides
- Vol. 99, 102337
Several neuropeptides involved in parkinsonian neuroprotection modulate the firing properties of nigral dopaminergic neurons
- Open Access
- 20 December 2022
- Published by Elsevier in Neurochemistry International
- Vol. 162, 105465
Changed firing activity of nigra dopaminergic neurons in Parkinson's disease
- 20 December 2022
- Published by Elsevier in Neurochemistry International
- Vol. 162, 105465
Open AccessChanged firing activity of nigra dopaminergic neurons in Parkinson's disease